Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P46
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -2.33% |
| Q2 2025 | -21.93% |
| Q1 2025 | -3.68% |
| Q4 2024 | -12.00% |
| Q3 2024 | 10.13% |
| Q2 2024 | -1.79% |
| Q1 2024 | 22.61% |
| Q4 2023 | -20.77% |
| Q3 2023 | 4.17% |
| Q2 2023 | -9.79% |
| Q1 2023 | 12.78% |
| Q4 2022 | 0.82% |
| Q3 2022 | -24.41% |
| Q2 2022 | -38.93% |
| Q1 2022 | 1.68% |
| Q4 2021 | 6.40% |
| Q3 2021 | 26.36% |
| Q2 2021 | -98.36% |
| Q1 2021 | 16.43% |
| Q4 2020 | -20.42% |
| Q3 2020 | 10.85% |
| Q2 2020 | -34.01% |
| Q1 2020 | -12.24% |
| Q4 2019 | 20.66% |
| Q3 2019 | 54.73% |
| Q2 2019 | -79.27% |
| Q1 2019 | -92.88% |
| Q4 2018 | 36.34% |
| Q3 2018 | 20.10% |
| Q2 2018 | -121.01% |
| Q1 2018 | -21.05% |
| Q4 2017 | 24.69% |
| Q3 2017 | -8.42% |
| Q2 2017 | -11.31% |
| Q1 2017 | 32.50% |
| Q4 2016 | -61.94% |
| Q3 2016 | 9.52% |
| Q2 2016 | 26.00% |
| Q1 2016 | 5.92% |
| Q4 2015 | 35.61% |